Illumina Newswire (Page 7)

Illumina Newswire (Page 7)

Comprehensive Real-Time News Feed for Illumina. (Page 7)

Results 121 - 140 of 1,388 in Illumina

  1. Insider Selling: Illumina Inc. (ILMN) EVP Sells 3,000 Shares of StockRead the original story w/Photo

    Dec 9, 2016 | AmericanBankingNews.com

    Illumina Inc. EVP Omead Ostadan sold 3,000 shares of the company's stock in a transaction on Thursday, December 8th. The stock was sold at an average price of $121.63, for a total transaction of $364,890.00.

    Comment?

  2. Illumina Inc. (ILMN) Price Target Cut to $100.00Read the original story w/Photo

    Dec 9, 2016 | IntersportsWire

    ... close. Several other equities research analysts have also recently weighed in on ILMN. CL King cut shares of Illumina from a "buy" rating to a "neutral" rating in a research report on Monday, August 22nd. Zacks Investment Research raised shares of ...

    Comment?

  3. Traders Buy Shares of Illumina Inc. (ILMN) on Weakness on Insider SellingRead the original story w/Photo

    Dec 9, 2016 | IntersportsWire

    Investors purchased shares of Illumina Inc. on weakness during trading hours on Wednesday after an insider sold shares in the company. $86.55 million flowed into the stock on the tick-up and $69.46 million flowed out of the stock on the tick-down, for a money net flow of $17.09 million into the stock.

    Comment?

  4. Illumina Inc. (ILMN) Rating Increased to Strong-Buy at Vetr Inc.Read the original story w/Photo

    Dec 9, 2016 | IntersportsWire

    ... previous close. Several other equities research analysts have also recently weighed in on ILMN. TheStreet cut Illumina from a "buy" rating to a "hold" rating in a research note on Monday. BTIG Research reaffirmed a "hold" rating on shares of ...

    Comment?

  5. Illumina Inc. (ILMN) Shares Gap Down Following Insider SellingRead the original story w/Photo

    Dec 9, 2016 | IntersportsWire

    Illumina Inc. 's share price gapped down prior to trading on Wednesday after an insider sold shares in the company. The stock had previously closed at $129.00, but opened at $126.40.

    Comment?

  6. Morgan Stanley Lowers Illumina Inc. (ILMN) Price Target to $100.00Read the original story w/Photo

    Dec 8, 2016 | AmericanBankingNews.com

    ... 19.02% from the stock's current price. Several other brokerages have also commented on ILMN. First Analysis lowered Illumina from an "equal weight" rating to an "underweight" rating and dropped their price objective for the company from $130.00 to ...

    Comment?

  7. Illumina, Inc. (NASDAQ:ILMN) - Top Stock from Healthcare SectorRead the original story w/Photo

    Dec 8, 2016 | The Daily Leicester

    The company has reported a price of $121.07 today, marking a change of -0.78%. Illumina, Inc. has a current return on equity of 21.80% while its debt to equity stands at 0.47.

    Comment?

  8. Illumina Inc. (ILMN) Forecasted to Earn FY2016 Earnings of $3.31 Per ShareRead the original story w/Photo

    Dec 8, 2016 | AmericanBankingNews.com

    Analysts at William Blair issued their FY2016 earnings per share estimates for shares of Illumina in a research report issued on Tuesday. William Blair analyst A. Murphy forecasts that the firm will earn $3.31 per share for the year.

    Comment?

  9. HEALTH: Another insight on PSFK for MembersRead the original story w/Photo

    Dec 2, 2016 | PSFK

    DNA sequencing just over a decade ago was an extremely expensive proposition costing approximately $3 billion dollars. Today, DNA sequencing, done mostly by San Diego-based company Illumina , has become a critical part of healthcare technology.

    Comment?

  10. Illumina Launches iHope Program to Identify Causes of Undiagnosed Genetic Diseases in ChildrenRead the original story

    Dec 1, 2016 | PressReleasePoint

    Dec. 1, 2016-- Illumina , Inc. today announced the iHope program, a philanthropic initiative aimed at identifying the genetic causes of undiagnosed rare diseases in children. With initial program partners Foundation for the Children of the Californias , Rare Genomics Institute , and UCSF Benioff Children's Hospital San Francisco , selected patients in financial need will receive clinical whole-genome sequencing performed by the Illumina Clinical Services Laboratory.

    Comment?

  11. Daily Business Report-Dec. 1, 2016Read the original story w/Photo

    Dec 1, 2016 | Uptown San Diego Examiner

    ... $90 million construction pipeline of six projects totaling 425,000 square feet across North County. San Diego-based Illumina has launched a philanthropic whole-genome sequencing program in conjunction with the Foundation for Children of the ...

    Comment?

  12. More Medtech Venture Cash Goes Into Series A RoundsRead the original story w/Photo

    Dec 1, 2016 | Seeking Alpha

    Medtech series A rounds are bigger than ever. Thanks to the joint-largest series A round the device sector has ever seen, the $100m funding of Illumina spin-off Grail Bio, the average size of a series A round so far this year is more than five times larger than the overall average for the last nine years .

    Comment?

  13. A look at a High Market Cap Stock: Illumina, Inc., ILMNRead the original story w/Photo

    Nov 30, 2016 | The Daily Leicester

    Illumina, Inc., ILMN is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Illumina, Inc., ILMN has a market cap of 20056.26.

    Comment?

  14. Smart Money Not Being Drawn to ICICI Bank LtdRead the original story w/Photo

    Nov 30, 2016 | Insider Monkey

    ... IBN to other stocks including Credit Suisse Group AG (ADR) (NYSE: CS ), Newmont Mining Corp (NYSE: NEM ), and Illumina, Inc. (NASDAQ: ILMN ) to get a better sense of its popularity. At Q3's end, a total of 22 of the hedge funds tracked by Insider ...

    Comment?

  15. Illumina clinical genomics chief bids adieuRead the original story w/Photo

    Nov 29, 2016 | Seeking Alpha

    In a regulatory filing , Illumina discloses that EVP, Clinical Genomics Tristan Orpin will resign in January.

    Comment?

  16. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    Nov 28, 2016 | Business Wire

    ... today the launch of an initial public offering ("IPO") of its Class A common shares. All of the 23,750,000... )--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Citi Global Healthcare Conference in ...

    Comment?

  17. Illumina to Webcast Live Presentation at the Citi Global Healthcare ConferenceRead the original story w/Photo

    Nov 28, 2016 | Business Wire

    The live webcast is scheduled to begin at 8:45 AM ET and will feature a brief overview of the company by Francis deSouza, President and CEO, followed by a question and answer session. The webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com .

    Comment?

  18. Illumina Inc. (ILMN) Given a $135.00 Price Target by Canaccord Genuity AnalystsRead the original story w/Photo

    Nov 27, 2016 | AmericanBankingNews.com

    ... analysts have also issued research reports about the company. JPMorgan Chase & Co. boosted their target price on Illumina from $185.00 to $200.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 27th. Cantor ...

    Comment?

  19. Illumina, Inc. (ILMN): Hedge Fund Ownership Half What It Was Last YearRead the original story w/Photo

    Nov 26, 2016 | Insider Monkey

    ... winners within the small-cap galaxy of stocks? We believe following the smart money is a good starting point. Illumina, Inc. (NASDAQ: ILMN ) shares didn't see a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The ...

    Comment?

  20. Illumina Inc. (ILMN) Shares Bought by Delta Lloyd NVRead the original story w/Photo

    Nov 25, 2016 | Daily Political

    Delta Lloyd NV increased its stake in shares of Illumina Inc. by 17.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,939 shares of the life sciences company's stock after buying an additional 1,896 shares during the period.

    Comment?